RecruitingNot ApplicableNCT07256704

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Hypnosis and Attention in Patients With a Neurological Disease

Sponsor

Luzerner Kantonsspital

Enrollment

48 participants

Start Date

Nov 18, 2025

Study Type

INTERVENTIONAL

Conditions

Traumatic Brain Injury Stroke Multiple Sclerosis

Summary

This feasibility study investigates the potential of hypnosis as a complementary therapy to improve attentional deficits and fatigue in patients with neurological diseases such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation methods. By integrating hypnosis with standard care, and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the practicality, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether hypnosis — a focused relaxation technique — can help improve attention and cognitive function in people recovering from stroke, traumatic brain injury (TBI), or multiple sclerosis (MS). **You may be eligible if...** - You have been diagnosed with stroke, traumatic brain injury, or multiple sclerosis - You are 18 or older - You are receiving inpatient or outpatient care at the Neurology and Neurorehabilitation Clinic - You understand German - You have provided written informed consent **You may NOT be eligible if...** - You have a psychiatric disorder - You have other conditions that would make hypnosis unsafe or inappropriate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHypnosis

Hypnosis sessions designed to improve attentional control and reduce fatigue in patients with neurological conditions (stroke, TBI, MS). The intervention involves guided hypnotic induction and suggestions tailored to enhance cognitive focus and energy management.

Locations(1)

Luzerner Kantonsspital

Lucerne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07256704

Related Trials

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

NCT066159731 location

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

NCT027842101 location

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT000012481 location

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

NCT053577811 location

Verbal Working Memory and Attention Remediation for Adults With Traumatic Brain Injury.

NCT043498521 location